The biomarker segment is witnessing speedy technological progress and superior demand for personalized drugs. So, to ensure affected individual usage of these new systems, a reimbursement framework should be worked on to satisfy the switching market scenario.Some exams look for only one biomarker. Other individuals look for numerous biomarkers simu